Up-to-date access to technology licensing opportunities worldwide.
Displaying 1..3 of 3 -
10
20
50
100
per page
number of views
addition date
development phase
The inactivation approach presented in this technology provides for a safe, non-infectious composition for vaccination against the corresponding agent.
More
Broad spectrum antiviral compounds for treatment of infection caused by enveloped viruses
More
Methods of producing a population of purified non-alloreactive antigen-specific T cells that recognize an antigen of interest
More
Displaying 1..3 of 3 -
10
20
50
100
per page
number of views
addition date
development phase
All rights reserved. Terms and Conditions | Contact us
